How do we choose optimal antithromboticagents aimed at different patients?
对于不同的患者，我们如何选择最佳的抗凝药物？
2
There were more catheter thrombi in the group of patients who received fondaparinux than the other antithromboticagents.
在急诊PCI患者中磺达肝癸钠组出现导管内血栓的发生率比其他抗凝血剂组多。
3
This paper introduces their mechanism function and clinical research illustrates their advantages compated with heparin believing that both hirudin and hirulog are new promising antithromboticagents.